Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis-Reference-Cited by-同舟云学术

Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis

Published:2001-10 Issue:4 Volume:38 Page:761-769
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Jinde Kiichiro,Nikolic-Paterson David J.,Huang Xiao R.,Sakai Hideto,Kurokawa Kiyoshi,Atkins Robert C.,Lan Hui Y.

Publisher

Elsevier BV

Subject

Nephrology

Reference33 articles.

1. Interstitial pathomechanisms underlying progressive tubulointerstitial damage;Strutz;Kidney Blood Press Res,1999

2. Role of myofibroblasts during normal tissue repair and excessive scarring: Interest of their assessment in nephropathies;Badid;Histol Histopathol,2000

3. Myofibroblast and α1(III) collagen expression in experimental tubulointerstitial nephritis;Tang;Kidney Int,1997

4. Myofibroblasts and the progression of crescentic glomerulonephritis;Goumenos;Nephrol Dial Transplant,1998

5. Myofibroblast-like cells produce mRNA for type I and III procollagens in chronic active hepatitis;Hogemann;Scand J Gastroenterol,1993

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IKKε-deficient macrophages impede cardiac repair after myocardial infarction by enhancing the macrophage–myofibroblast transition;Experimental & Molecular Medicine;2024-09-12

2. Fibrotic Extracellular Matrix Preferentially Induces a Partial Epithelial-Mesenchymal Transition Phenotype in a 3-D Agent Based Model of Fibrosis;2024-06-22

3. IKKε-deficient macrophages impede cardiac repair after myocardial infarction by enhancing macrophage-myofibroblast transition;2024-03-01

4. Keratin Expression in Podocytopathies, ANCA-Associated Vasculitis and IgA Nephropathy;International Journal of Molecular Sciences;2024-02-02

5. Fibrotic Extracellular Matrix Preferentially Induces a Partial Epithelial-Mesenchymal Transition Phenotype in a 3-D Agent Based Model of Fibrosis;2024